Lindsay Ledwich is a Rheumatology/Immunology physician affiliated with Allegheny Health Network. OpenAlex indexes 5 publications with 230 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
965 S Highway 25 W Ste 1
Williamsburg, KY 407691608
Telephone
606-549-2656Provider last certified this registry record 4 Jun 2026.
Industry payments
37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202425 payments
- ABBVIE INC.Program year202419 payments
- Janssen Biotech, Inc.Program year202412 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
33.1%Corticosteroid22.9%Prednisone100%Part D≥87 patientsAminosalicylate8.2%Sulfasalazine88%Sulfasalazine Dr12%Part D<11 patients+ 1 more class in this area
Antiparasitic
23.4%Antimalarial23.4%Hydroxychloroquine Sulfate100%Part D≥95 patientsAnti-infectives
12.9%Tetracycline-class Drug9.5%Doxycycline Hyclate64%Minocycline Hcl36%Part D<11 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor2.3%Valacyclovir100%Part D≥16 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hydroxychloroquine Use and Decreased Risk of Diabetes in Rheumatoid Arthritis Patients
JCR Journal of Clinical Rheumatology
2011 - Patterns of preventive health services in rheumatoid arthritis patients compared to a primary care patient population
Rheumatology International
2010 - A Rare Lymphoma in a Patient with Amyopathic Dermatomyositis
American Journal of Clinical Dermatology
2010 - Screening and Treatment of Glucocorticoid-Induced Osteoporosis in Rheumatoid Arthritis Patients in an Urban Multispecialty Practice
JCR Journal of Clinical Rheumatology
2009
Similar KOLs
Other experts from the same institution or the same specialty.
Susan Manzi, MD
Allegheny Health Network
Sushil Beriwal, MD
Allegheny Health Network
Srinivas Murali, MD
Allegheny Health Network
Hiran Fernando, MD
Allegheny Health Network
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”